Active Clinical Trials - Pulmonx Australia: COPD Care with Zephyr Endobronchial Valves

A trial to evaluate the safety and effectiveness of AeriSeal System to block collateral ventilation (CV) and convert a severe emphysema patient from CV+ to CV- status.

CONVERT II is currently enrolling patients in sites around the world.

This study has 19 locations:

United States

Detroit, Michigan, United States, 48202

Recruiting:

Henry Ford Hospital

Principal Investigator:

Avi Cohen, MD

Contact:

[email protected]

Philadelphia, Pennsylvania, United States, 19107

Recruiting:

Penn Medicine

Principal Investigator:

Kevin Ma, MD

Contact:

[email protected]

Pennsylvania, United States, 19140

Recruiting:

Temple University

Principal Investigator:

Gerard Criner, MD

Contact:

[email protected]

Australia

Adelaide, Australia

Recruiting:

Royal Adelaide Hospital

Principal Investigator:

Phan Nguyen, MD

Contact:

[email protected]

Brisbane, Australia

Recruiting:

Wesley Hospital

Principal Investigator:

Farzad Bashirzadeh, MD

Contact:

[email protected]

Macquarie Park, Australia

Recruiting:

Macquarie University

Principal Investigator:

Alvin Ing, MD

Contact:

[email protected]

Austria

Vienna, Austria

Recruiting:

Klinik Floridsdorf

Principal Investigator:

Arschang Valipour, MD

Contact:

[email protected]

Denmark

Copenhagen, Denmark

Recruiting:

Rigshospitalet

Principal Investigator:

Michael Perch, MD

Contact:

[email protected]

France

Limoges, France

Recruiting:

CHU Limoges

Principal Investigator:

Thomas Egenod, MD

Contact:

[email protected]

Strasbourg, France

Recruiting:

CHRU Strasbourg

Principal Investigator:

Michele Porzio, MD

Contact:

[email protected]

Toulouse, France

Recruiting:

CHU Toulouse

Principal Investigator:

Nicolas Guibert, MD, PhD

Contact:

[email protected]

Germany

Essen, Germany, 45239

Recruiting:

Ruhrlandklinik - West German Lung Center

Principal Investigator:

Kaid Darwiche, MD

Contact:

[email protected]

Halle, Germany

Recruiting:

Universitätsklinikum Halle

Principal Investigator:

Stephan Eisenmann, MD, PhD

Contact:

[email protected]

Hamburg, Germany, 22307

Recruiting:

Asklepios Klinik Barmbek

Principal Investigator:

Ralf Eberhardt, MD

Contact:

[email protected]

Heidelberg, Germany, 69126

Recruiting:

Thoraxklinik am Universitats klinikum Heidelberg

Principal Investigator:

Felix Herth, MD, PhD

Contact:

[email protected]

Italy

Brescia, Italy, 25123

Recruiting:

ASST Spedali Civili, University Hospital

Principal Investigator:

Michela Bezzi, MD, PhD

Contact:

[email protected]

Netherlands

Groningen, Netherlands

Recruiting:

University Medical Center Groningen

Principal Investigator:

Dirk-Jan Slebos, MD, PhD

Contact:

[email protected]

Spain

Valencia, Spain, 46026

Recruiting:

Hospital Universitario y Politecnico La Fe

Principal Investigator:

Enrique Cases Viedma, MD, PhD

Contact:

[email protected]

United Kingdom

London, England, United Kingdom, SW3 6NP

Recruiting:

Royal Brompton Hospital

Principal Investigator:

Pallav Shah, MD

Contact:

[email protected]

Please visit clinicaltrials.gov/study/NCT06035120 for additional trial information.

CONVERT II Clinical Trial Information

Review the clinical trial brochure to see the study design and patient eligibility criteria.